Early combination therapy could translate into fewer downstream hospitalizations and lower costs associated with dialysis and cardiovascular complications.

The countdown is on with Argenica’s phase II trial results of lead drug ARG-007 in acute ischaemic stroke patients forecast .

You're discharged from hospital with some painkillers but aren't sure if they're safe to take with the heart medication you've been prescribed for ...

Certain gut bacteria were linked to higher risk of heart damage in older patients with breast cancer, suggesting a possible ...

New European guidelines redefine Metabolic dysfunction-associated steatotic liver disease (MASLD) care, offering clearer ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that ...

Healthier people cost less. Figure out what could keep them well, and the government money spent on the discovery may well be ...

Diagnosed with melanoma skin cancer, John was originally told he had 12 months to live — but after pushing for further ...

Shares open down; Fortescue says it and China are in lock step amid historic loan; Iress confirms buyout talks with ...

Discover the latest breakthroughs in oncology, including FDA approvals and innovative therapies reshaping cancer treatment ...

Dr. Annu Navani stands at the forefront of innovation in clinical Orthobiologics and Longevity medicine. A triple-board certified physician in Anesthesiology, Pain Medicine, and Regenerative Medicine, ...